Disclosures for "Intraputaminal AAV-CAv1.3-shRNA Averts Levodopa-induced Dyskinesias and Ameliorates Long-standing Parkinsonian Motor Deficits in Aged Parkinsonian Macaques"
-
The institution of Dr. Caulfield has received research support from Department of Defense.
-
Prof. Steece-Collier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for RegenxBio. Prof. Steece-Collier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pontifax. The institution of Prof. Steece-Collier has received research support from NIH/NINDS.
-
Ms. Vander Werp has nothing to disclose.
-
Mr. Muller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for RYNE Biotechnology.
-
Ms. Stancati has nothing to disclose.
-
The institution of Timothy Collier has received research support from NIH.
-
Prof. Manfredsson has received personal compensation for serving as an employee of Seelos Therapeutics . Prof. Manfredsson has stock in NVector. Prof. Manfredsson has stock in Neuralina. Prof. Manfredsson has stock in Cavgene theraputics. Prof. Manfredsson has received intellectual property interests from a discovery or technology relating to health care. Prof. Manfredsson has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. Chu has nothing to disclose.
-
An immediate family member of Dr. Sandoval has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SEELOS therapeutics. Dr. Sandoval has stock in nVector. An immediate family member of Dr. Sandoval has stock in nVector. An immediate family member of Dr. Sandoval has stock in CavGene. An immediate family member of Dr. Sandoval has stock in Neuralina. Dr. Sandoval has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Sandoval has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Sandoval has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Sandoval has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Kordower has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Seelos Inc. Dr. Kordower has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Abbvie Inc. Dr. Kordower has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Inhibikase Inc. Dr. Kordower has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Kordower has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Renovacor/Rocket Pharm. Dr. Kordower has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kirkland and Ellis Attorney's at Law. Dr. Kordower has stock in Inhibikase Inc. The institution of Dr. Kordower has received research support from Michael J. Fox Foundation. The institution of Dr. Kordower has received research support from Michael J. Fox Foundation. The institution of Dr. Kordower has received research support from Michael J. Fox Foundation. The institution of Dr. Kordower has received research support from Aligning Science Against Parkinson's (ASAP). The institution of Dr. Kordower has received research support from Biogen. The institution of Dr. Kordower has received research support from Abbvie. The institution of Dr. Kordower has received research support from Abbvie.